OncoMed Pharmaceuticals Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
38.5 M |
Public Float |
28.42 M |
OncoMed Pharmaceuticals Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.28 |
Market Cap |
$103.96 M |
Shares Outstanding |
38.5 M |
Public Float |
25.73 M |
Address |
800 Chesapeake Drive Redwood City California 94063 United States |
Employees | - |
Website | http://www.oncomed.com |
Updated | 09/14/2018 |
OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. |